Tigris Pharmaceuticals

ACTIVE

佛罗里达州李县, 佛罗里达州, United Stateswww.tigrispharma.comPrivate1–10 employeesEstablished: 2005-01-01

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2005

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

100.0%

Trial Status Distribution

Completed

50.0%

Terminated

25.0%

Withdrawn

25.0%

Clinical Trials

Trials sponsored by this organization (4)

Study of AFP464 +/- Faslodex in ER + Breast Cancer

Phase 2

Terminated

interventional

May 20117 participants

Efficacy Study of Aminoflavone Prodrug to Treat Breast Cancer

Phase 2

Withdrawn

interventional

Apr 201050 participants

A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL)

Phase 2

Completed

interventional

Nov 200711 participants

Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix

Phase 2

Completed

interventional

Jan 2006147 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations